Open AccessImpact of COVID-19-related care disruptions on cervical cancer screening in the United States
Author(s) -
Emily A. Burger,
Erik E.L. Jansen,
James Killen,
Inge Mcm de Kok,
Megan A. Smith,
Stephen Sy,
Niels Dunnewind,
Nicole G. Campos,
Jennifer S. Haas,
Sarah Kobrin,
Aruna Kamineni,
Karen Canfell,
Jane J. Kim
Publication year - 2021
Publication title -
journal of medical screening
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 64
eISSN - 1475-5793
pISSN - 0969-1413
DOI - 10.1177/09691413211001097
Subject(s) - colposcopy , medicine , cervical screening , cytology , cervical cancer , human papillomavirus , gynecology , pandemic , cervical cancer screening , covid-19 , obstetrics , cancer , pathology , disease , infectious disease (medical specialty)
To quantify the secondary impacts of the COVID-19 pandemic disruptions to cervical cancer screening in the United States, stratified by step in the screening process and primary test modality, on cervical cancer burden.